Therapies based on targeting Epstein‐Barr virus lytic replication for EBV‐associated malignancies

In recent years, Epstein‐Barr virus (EBV) lytic infection has been shown to significantly contribute to carcinogenesis. Thus, therapies aimed at targeting the EBV lytic cycle have been developed as novel strategies for treatment of EBV‐associated malignancies. In this review, focusing on the viral l...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hongde, Hu, Jianmin, Luo, Xiangjian, Bode, Ann M., Dong, Zigang, Cao, Ya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029825/
https://www.ncbi.nlm.nih.gov/pubmed/29751367
http://dx.doi.org/10.1111/cas.13634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029825/
https://www.ncbi.nlm.nih.gov/pubmed/29751367
http://dx.doi.org/10.1111/cas.13634

Ejemplares similares